A-Alpha Bio
Biotechnology ResearchView the employees at
A-Alpha Bio-
Leah Homad Senior Research Assocate at A-Alpha Bio
-
Seattle, Washington, United States
-
Rising Star
James Harrang Machine Learning Scientist at A-Alpha Bio-
Seattle, Washington, United States
-
Top 10%
David Younger Co-Founder / CEO at A-Alpha Bio - We're hiring!-
Seattle
-
Top 5%
Ruchi Bansal PhD | Scientist | Research | Cell Culture | Love to Cook | Enjoy Needlepoint | Let's Connect!-
Top 5%
Cristina Wolf Senior Process Engineer at A-Alpha Bio-
Seattle, Washington, United States
-
Top 10%
Overview
A-Alpha Bio is a biotechnology company using synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions. We pursue our mission of improving human health through an internal therapeutics pipeline and by partnering with industry-leading pharmaceutical and technology companies. Current approaches for measuring protein-protein interactions are insufficient for many drug development applications due to low accuracy or throughput. We are a team of synthetic biologists, structural biologists, and next-generation sequencing experts who have come together to remove this industry-wide bottleneck. Our proprietary experimental platform, AlphaSeq, generates high-resolution data to discover rare and effective antibodies, identify degradable neo-substrates for molecular glues, and generate massive protein-protein interaction datasets to map the protein binding landscape. Our AlphaBind platform then leverages these data to train predictive machine learning models to further accelerate the discovery and optimization of high-impact therapeutics. A-Alpha Bio, Inc. was founded in 2017 as a spinout from the University of Washington's Institute for Protein Design and Center for Synthetic Biology and is based in Seattle, Washington.
-